- Type / Class
- Equity / Common Stock
- Shares outstanding
- 158,835,667
- Total 13F shares
- 98,807,721
- Share change
- -134,974
- Total reported value
- $4,765,076,153
- Put/Call ratio
- 118%
- Price per share
- $48.20
- Number of holders
- 233
- Value change
- -$16,595,617
- Number of buys
- 122
- Number of sells
- 121
Quarterly Holders Quick Answers
What is CUSIP 88322Q108?
CUSIP 88322Q108 identifies TGTX - TG THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 88322Q108:
Top shareholders of TGTX - TG THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
9.3%
|
14,827,136
|
$771,308,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.9%
|
10,970,863
|
$570,703,000 | — | 31 Dec 2020 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
5.5%
|
8,685,471
|
$451,818,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.4%
|
8,556,286
|
$445,099,000 | — | 31 Dec 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.1%
|
4,917,833
|
$255,825,000 | — | 31 Dec 2020 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
2.8%
|
4,440,459
|
$230,993,000 | — | 31 Dec 2020 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.6%
|
4,078,158
|
$212,146,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
3,712,842
|
$193,142,000 | — | 31 Dec 2020 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
2%
|
3,202,061
|
$166,571,000 | — | 31 Dec 2020 | |
| Invesco Ltd. |
13F
|
Company |
1.1%
|
1,781,292
|
$92,663,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
1,778,387
|
$92,511,000 | — | 31 Dec 2020 | |
| Artal Group S.A. |
13F
|
Company |
0.94%
|
1,500,000
|
$78,030,000 | — | 31 Dec 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.88%
|
1,400,845
|
$72,872,000 | — | 31 Dec 2020 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.85%
|
1,355,852
|
$70,532,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.85%
|
1,354,558
|
$70,464,000 | — | 31 Dec 2020 | |
| Lion Point Capital, LP |
13F
|
Company |
0.84%
|
1,327,734
|
$69,068,000 | — | 31 Dec 2020 | |
| NORGES BANK |
13F
|
Company |
0.8%
|
1,275,493
|
$66,351,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.77%
|
1,226,427
|
$63,798,000 | — | 31 Dec 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
0.64%
|
1,010,227
|
$52,554,000 | — | 31 Dec 2020 | |
| CARILLON TOWER ADVISERS, INC. |
13F
|
Company |
0.62%
|
992,041
|
$51,606,000 | — | 31 Dec 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.55%
|
868,479
|
$45,178,000 | — | 31 Dec 2020 | |
| Eversept Partners, LP |
13F
|
Company |
0.54%
|
863,851
|
$44,937,529 | — | 31 Dec 2020 | |
| Capital World Investors |
13F
|
Company |
0.54%
|
850,000
|
$44,217,000 | — | 31 Dec 2020 | |
| Logos Global Management LP |
13F
|
Company |
0.54%
|
850,000
|
$44,217,000 | — | 31 Dec 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.47%
|
748,604
|
$38,942,000 | — | 31 Dec 2020 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.47%
|
740,336
|
$38,512,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.46%
|
727,169
|
$37,828,000 | — | 31 Dec 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.43%
|
678,766
|
$35,310,000 | — | 31 Dec 2020 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.4%
|
628,172
|
$32,678,000 | — | 31 Dec 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.36%
|
570,677
|
$29,686,618 | — | 31 Dec 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.36%
|
567,326
|
$29,512,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.34%
|
544,576
|
$28,329,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.33%
|
528,345
|
$27,484,000 | — | 31 Dec 2020 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.31%
|
489,000
|
$25,438,000 | — | 31 Dec 2020 | |
| ARDSLEY ADVISORY PARTNERS LP |
13F
|
Company |
0.25%
|
400,000
|
$20,808,000 | — | 31 Dec 2020 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.25%
|
398,271
|
$20,719,000 | — | 31 Dec 2020 | |
| Opaleye Management Inc. |
13F
|
Company |
0.24%
|
387,500
|
$20,158,000 | — | 31 Dec 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.24%
|
382,988
|
$19,923,000 | — | 31 Dec 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.23%
|
368,000
|
$19,143,000 | — | 31 Dec 2020 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
0.21%
|
339,858
|
$17,679,000 | — | 31 Dec 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.18%
|
281,084
|
$14,622,000 | — | 31 Dec 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.17%
|
275,063
|
$14,309,000 | — | 31 Dec 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.17%
|
269,672
|
$14,028,000 | — | 31 Dec 2020 | |
| BRIDGER MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
256,897
|
$13,364,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.16%
|
253,910
|
$13,209,000 | — | 31 Dec 2020 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.16%
|
250,000
|
$13,005,000 | — | 31 Dec 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.15%
|
232,915
|
$12,116,000 | — | 31 Dec 2020 | |
| Swiss National Bank |
13F
|
Company |
0.14%
|
229,100
|
$11,918,000 | — | 31 Dec 2020 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.14%
|
222,993
|
$11,600,000 | — | 31 Dec 2020 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.13%
|
206,821
|
$10,759,000 | — | 31 Dec 2020 |
Institutional Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q1 2021
As of 31 Mar 2021,
TG THERAPEUTICS, INC. - Common Stock (TGTX) was held by
233 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
98,807,721 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., LORD, ABBETT & CO. LLC, RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, ALKEON CAPITAL MANAGEMENT LLC, STATE STREET CORP, Capital World Investors, and MAVERICK CAPITAL LTD.
This page lists
234
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
246
Q1 2021 holders
233
Holder diff
-13
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.